BECTON DICKINSON AND CO (BDX) Stock Price & Overview

NYSE:BDX • US0758871091

Current stock price

155.92 USD
-0.31 (-0.2%)
At close:
157 USD
+1.08 (+0.69%)
After Hours:

The current stock price of BDX is 155.92 USD. Today BDX is down by -0.2%. In the past month the price decreased by -14.56%. In the past year, price decreased by -31.46%.

BDX Key Statistics

52-Week Range153.745 - 229.798
Current BDX stock price positioned within its 52-week range.
1-Month Range153.745 - 183.73
Current BDX stock price positioned within its 1-month range.
Market Cap
44.397B
P/E
11.22
Fwd P/E
11.44
EPS (TTM)
13.90
Dividend Yield
2.68%

BDX Stock Performance

Today
-0.2%
1 Week
-3.54%
1 Month
-14.56%
3 Months
-20.58%
Longer-term
6 Months -15.54%
1 Year -31.46%
2 Years -36.99%
3 Years -37.01%
5 Years -35.88%
10 Years +2.70%

BDX Stock Chart

BECTON DICKINSON AND CO / BDX Daily stock chart

BDX Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to BDX. When comparing the yearly performance of all stocks, BDX is a bad performer in the overall market: 86.86% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

BDX Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to BDX. While BDX has a great profitability rating, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BDX Earnings

On February 9, 2026 BDX reported an EPS of 2.91 and a revenue of 5.25B. The company beat EPS expectations (2.45% surprise) and beat revenue expectations (1.04% surprise).

Next Earnings DateApr 29, 2026
Last Earnings DateFeb 9, 2026
PeriodQ1 / 2026
EPS Reported$2.91
Revenue Reported5.252B
EPS Surprise 2.45%
Revenue Surprise 1.04%

BDX Forecast & Estimates

20 analysts have analysed BDX and the average price target is 204.45 USD. This implies a price increase of 31.13% is expected in the next year compared to the current price of 155.92.

For the next year, analysts expect an EPS growth of -12.81% and a revenue growth -11.72% for BDX


Analysts
Analysts74
Price Target204.45 (31.12%)
EPS Next Y-12.81%
Revenue Next Year-11.72%

BDX Groups

Sector & Classification

BDX Financial Highlights

Over the last trailing twelve months BDX reported a non-GAAP Earnings per Share(EPS) of 13.9. The EPS decreased by -0.07% compared to the year before.


Income Statements
Revenue(TTM)21.92B
Net Income(TTM)1.76B
Industry RankSector Rank
PM (TTM) 8.01%
ROA 3.2%
ROE 6.95%
Debt/Equity 0.67
Chartmill High Growth Momentum
EPS Q2Q%-15.16%
Sales Q2Q%1.63%
EPS 1Y (TTM)-0.07%
Revenue 1Y (TTM)6.22%

BDX Ownership

Ownership
Inst Owners96.07%
Shares284.74M
Float283.55M
Ins Owners0.36%
Short Float %4.87%
Short Ratio5.35

About BDX

Company Profile

BDX logo image Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.

Company Info

IPO: 1963-09-25

BECTON DICKINSON AND CO

One Becton Drive

Franklin Lakes NEW JERSEY 07417 US

CEO: Thomas E. Polen

Employees: 72000

BDX Company Website

BDX Investor Relations

Phone: 12018476800

BECTON DICKINSON AND CO / BDX FAQ

Can you describe the business of BECTON DICKINSON AND CO?

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.


What is the current price of BDX stock?

The current stock price of BDX is 155.92 USD. The price decreased by -0.2% in the last trading session.


Does BECTON DICKINSON AND CO pay dividends?

BECTON DICKINSON AND CO (BDX) has a dividend yield of 2.68%. The yearly dividend amount is currently 4.16.


What is the ChartMill technical and fundamental rating of BDX stock?

BDX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


How is the market expecting BDX stock to perform?

20 analysts have analysed BDX and the average price target is 204.45 USD. This implies a price increase of 31.13% is expected in the next year compared to the current price of 155.92.


What is the GICS sector and industry of BDX stock?

BECTON DICKINSON AND CO (BDX) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


What is the ownership structure of BECTON DICKINSON AND CO (BDX)?

You can find the ownership structure of BECTON DICKINSON AND CO (BDX) on the Ownership tab.